There are 640 papers on cirrhosis in aging research: 56 trials and 343 observational studies in people, 43 in animals, 3 in cells, 170 reviews. The newest story, Nov 17, 2026: “Model infers biological roles of unidentified molecules”.
Human studies link short telomeres, accelerated biological aging, and frailty with higher cirrhosis risk. Cirrhosis is also associated with sarcopenia, although a study of elderly hospitalized patients finds no clear link. One study in aging male mice reports lower cirrhosis risk with exercise.
110 findings in 89 papers from 2016 to 2026, 19 of them since April 2026
Cirrhosis impairs knee extension strength in humans (versus age-matched control) (SMD: 3.48, 95% CI 2.35-4.61, p<0.001).
“Muscle strength was impaired in patients with cirrhosis versus age-matched control (standardized mean difference, SMD: 3.48, 95% CI 2.35-4.61, I2 = 96.5%, p<0.001)”
Cirrhosis showed no clear effect on mitochondrial membrane potential in human cells (BMSCs from patients versus healthy volunteers).
“mitochondrial membrane potential, oxygen consumption rate, and expression of mitochondria-related genes such as cytochrome c oxidase 1 were not significantly different between BCs and BPs”
CellsBMSCs from patients versus healthy volunteersbone marrow-derived mesenchymal stem cellsn = 6
Cirrhosis decreases population doubling time in human cells (BMSCs from patients versus healthy volunteers, passages 3-5) (65.3±11.1 h vs 83.7±9.2 h; 18.4 h shorter).
“the average population doubling time for P3-P5 in BPs was approximately 65.3±11.1 h, which is 18.4 h shorter than that in BCs (83.7±9.2 h)”
CellsBMSCs from patients versus healthy volunteers, passages 3-5bone marrow-derived mesenchymal stem cellsn = 6
Cirrhosis is associated with mortality in humans (sepsis survivors) (HR 1.562).
“Neoplasia (hazard ratio [HR], 2.011), liver cirrhosis (HR, 1.562), and dementia (HR, 1.304) were the comorbidities most strongly associated with mortality.”
Humanssepsis survivorswithin 2 years after hospital discharge
European journal of trauma and emergency surgery : official publication of the European Trauma Society·
Cirrhosis is linked with a higher risk of mortality in humans (controlling for ISS category) (aOR 3.03 (mild), 3.63 (moderate), 3.46 (severe)).
“Patients who had cirrhosis or congestive heart failure (CHF) were at increased odds of mortality after adjusting for mild (aOR: 3.03, 1.61), moderate (aOR: 3.63, 2.14), and severe (aOR: 3.46, 1.93) injuries, respectively.”
Cirrhosis predicts mortality in humans (upper gastrointestinal bleeding) (OR 2.88, 95% CI 1.88-17.34).
“cirrhosis (OR: 2.88, 95% CI: 1.88-17.34; P = .04) and being an impatient (OR: 3.90; 95% CI: 1.11-20; P = .035) were independent risk factors for mortality in older patients.”
Frailty is linked with a higher risk of cirrhosis in humans (HR 1.90, 95% CI 1.66-2.18).
“Similar associations were observed for cirrhosis, the corresponding HRs (95% CIs) for non-frailty, pre-frailty, and frailty were 1.00 (reference), 1.29 (1.20, 1.38), and 1.90 (1.66, 2.18).”
Alcohol raises the risk of cirrhosis in humans (current consumption).
“levels of current alcohol consumption are associated with increased risks for cancers of the breast, colorectum, oesophagus, larynx, lip and oral cavities, pharynx, liver, stomach, pancreas and prostate, as well as pancreatitis, cirrhosis”
GLP-1 receptor agonists are associated with cirrhosis in humans (Patients with type 2 diabetes and chronic viral hepatitis; compared with nonusers) (HR 0.70, 95% CI 0.56-0.86; P<0.001).
“cirrhosis (HR 0.70, 95% CI 0.56-0.86; P<0.001)”
HumansPatients with type 2 diabetes and chronic viral hepatitis; compared with nonusersn = 9,499
Statins are linked with a lower risk of cirrhosis in humans (HR 0.74 [95% CI 0.70-0.78], p < 0.0001).
“In adjusted models, baseline statin use was significantly associated with a reduced risk of cirrhosis over 10 years (HR 0.74 [95% confidence interval 0.70-0.78], p < 0.0001).”
Humansin patients with chronic liver enzyme elevation primarily associated with metabolic dysfunction10 years
Proteomics-derived sarcopenia score is associated with cirrhosis in humans (Out-of-fold ProSS) (HR 2.39, 95% CI 2.15–2.65).
“fold-specific out-of-fold ProSS values were associated with incident MASLD (HR 1.49 per 1-SD increase, 95% CI 1.38–1.61) and cirrhosis (HR 2.39, 95% CI 2.15–2.65).”
MASLD and sarcopenia-related abnormality status is associated with cirrhosis in humans (Adjusted hazard ratios of 3.93, 7.36, and 8.48, respectively).
“adjusted hazard ratios increased from 3.93 to 7.36 then 8.48 with MASLD alone, coexisting MASLD with low MS overall and coexisting MASLD, low MS and obesity, respectively.”
HumansMASLD alone, coexisting MASLD with low muscle strength, and coexisting MASLD with low muscle strength and obesityMedian follow-up of 13.8 yearsn = 438,748
Human studies link cirrhosis with short telomeres, genetic predisposition to accelerated liver aging, and frailty; older age is associated with higher risk in people with chronic hepatitis B. Cirrhosis is also linked with worse cognition and higher mortality after osteoporotic hip fracture. A mouse study reports that exercise reduces cirrhosis risk in aging males.
Summary rewritten as its findings changed.
As it read before
A human study shows SAFE and FIB-4 predict cirrhosis in steatotic liver disease. Another reports lower cirrhosis risk with GLP-1 receptor agonists in liver transplant recipients with diabetes, while a review describes lower risk with antiviral therapy in HBV infection.
In computational benchmarks, generated descriptions more closely matched reference descriptions than competing methods, without requiring the molecules behind the signals…In computational benchmarks, generated descriptions more closely matched reference descriptions than competing methods, without requiring the molecules behind the signals to be identified first.
Over about 14 years, muscle loss was linked to severe liver scarring, with a relative risk measure called a hazard ratio of 1.58 versus no muscle loss.Over about 14 years, muscle loss was linked to severe liver scarring, with a relative risk measure called a hazard ratio of 1.58 versus no muscle loss.